Agenus Inc (NASDAQ:AGEN)’s Chairman & Ceo H Garo Armen procured 4,886 shares of Common Stock at a price of $2.7 per share, representing issuance for payment of 33% of the Chairman & Ceo’s base salary, for May 2014. Following the reported transaction, Mr. Armen directly owns more than 1, 6 million shares at this biotechnology company, and 4,000 shares through indirect holdings. The company hadn’t witnessed any insider transaction for over 3 years, when it was Mr. Armen who acquired about 2 million shares over Q3 2011.
Moreover, important hedge funds have commenced activity at Agenus Inc (NASDAQ:AGEN) this quarter. Daniel Gold’s Qvt Financial owns more than 9 million shares, worth $28 million, amount which currently represents 1.61% of the fund’s Equity Portfolio. Additionally, Samuel Isaly’s Orbimed Advisors and Richard Driehaus’s Driehaus Capital have also engaged in activity at the company, now holding, respectively, 5 million shares, valued at $16 million, and 1 million shares, worth $3 million. These amounts currently represent 0.19% and 0.11% of these funds’ Equity Portfolio.